Lessee, Operating Lease, Liability, Undiscounted Excess Amount of HERON THERAPEUTICS, INC. /DE/ from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • HERON THERAPEUTICS, INC. /DE/ Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Sep 2025 was $5,000, a 97% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,000 -$155,000 -97% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $24,000 -$209,000 -90% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $55,000 -$263,000 -83% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $101,000 -$315,000 -76% 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $160,000 -$367,000 -70% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $233,000 -$403,000 -63% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $318,000 -$447,000 -58% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $416,000 -$487,000 -54% 31 Dec 2023 10-K 12 Mar 2024 2023 FY
Q3 2023 $527,000 -$529,000 -50% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $636,000 -$582,000 -48% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $765,000 -$625,000 -45% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $903,000 -$666,000 -42% 31 Dec 2022 10-K 29 Mar 2023 2022 FY
Q3 2022 $1,056,000 -$1,359,000 -56% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $1,218,000 -$1,475,000 -55% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $1,390,000 -$1,588,000 -53% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $1,569,000 -$1,704,000 -52% 31 Dec 2021 10-K 28 Feb 2022 2021 FY
Q3 2021 $2,415,000 -$1,172,000 -33% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $2,693,000 -$1,218,000 -31% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $2,978,000 -$1,266,000 -30% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $3,273,000 -$68,000 -2% 31 Dec 2020 10-K 24 Feb 2021 2020 FY
Q3 2020 $3,587,000 +$927,000 +35% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $3,911,000 +$993,000 +34% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $4,244,000 +$1,089,000 +35% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $3,341,000 31 Dec 2019 10-K 02 Mar 2020 2019 FY
Q3 2019 $2,660,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $2,918,000 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $3,155,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.